https://orcid.org/0000-0003-4174-4586
Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yih-Lin Chung & Mei-Ling Wu. (2021) Clonal dynamics of tumor-infiltrating T-cell receptor beta-chain repertoires in the peripheral blood in response to concurrent chemoradiotherapy for Epstein–Barr virus-associated nasopharyngeal carcinoma. OncoImmunology 10:1.
Read now
Read now
Valentin Baloche, François-Régis Ferrand, Anna Makowska, Caroline Even, Udo Kontny & Pierre Busson. (2020) Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challenges. Expert Opinion on Therapeutic Targets 24:6, pages 545-558.
Read now
Read now
Articles from other publishers (31)
Haipeng Zhang, Jing Chen, Qianbing Zhang, Lingfeng Yu, Xiaohong Li & Sha Wu. (2023) Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunities. Medicine Advances.
Crossref
Crossref
Qingyi Huo, Jiang Lv, Jianzhong Zhang, Haiqiong Huang, Huayong Hu, Yaoxin Zhao, Xinrui Zhang, Yingqi Wang, Yiyi Zhou, Junchao Qiu, Yanmei Ye, Aiqun Huang, Yanhong Chen, Le Qin, Dajiang Qin, Peng Li & Gang Cai. (2023) c-Met is a chimeric antigen receptor T-cell target for treating recurrent nasopharyngeal carcinoma. Cytotherapy 25:10, pages 1037-1047.
Crossref
Crossref
Wenya Zheng, Tao Yan, Dongjiao Liu, Geng Chen, Yingjuan Wen, Xiuli Rao, Yizhe Wang, Huijuan Zheng, Jiahong Yang & Hua Peng. (2023) Clinical evaluation of radiation-induced sinusitis by MRI-based scoring system in nasopharyngeal carcinoma patients. Radiation Oncology 18:1.
Crossref
Crossref
Yangge Wu, Xiaoyue Zhang, Can Liu, Zhengshuo Li, Yuqing Wen, Run Zheng, Chenxiao Xu, Junrui Tian, Lingyu Wei, Jia Wang, Qun Yan, Xiang Zheng & Jian Ma. (2023) Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. Journal of Biological Chemistry 299:9, pages 105082.
Crossref
Crossref
Shweta Mahajan, Michiel Bongaerts, Jose Hardillo, Anna Tsang, Kwok W Lo, Dian Kortleve, Brigette Ma & Reno Debets. (2023) Transcriptomics of Epstein–Barr virus aids to the classification of T-cell evasion in nasopharyngeal carcinoma. Current Opinion in Immunology 83, pages 102335.
Crossref
Crossref
Aviyah Peri, Nadja Salomon, Yochai Wolf, Sebastian Kreiter, Mustafa Diken & Yardena Samuels. (2023) The landscape of T cell antigens for cancer immunotherapy. Nature Cancer 4:7, pages 937-954.
Crossref
Crossref
Katherine Xu, Emma De Ravin, Neeraj Suresh, Robert M. Brody & Karthik Rajasekaran. (2022) A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials. World Journal of Otorhinolaryngology - Head and Neck Surgery 9:2, pages 174-182.
Crossref
Crossref
Shaoli Wang, Siying Chen, Qionglei Zhong & Yan Liu. (2022) Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era. Journal of Cancer Research and Clinical Oncology 149:5, pages 2071-2079.
Crossref
Crossref
Rajaa Benzeid, Amina Gihbid, Nadia Benchekroun, Nezha Tawfiq, Abdellatif Benider, Mohammed Attaleb, Abdelkarim Filali Maltouf, Mohammed El Mzibri, Meriem Khyatti & Imane Chaoui. (2023) Recent Advances in Nasopharyngeal Cancer Management: From Diagnosis
to Theranostics. Current Pharmacogenomics and Personalized Medicine 20:1, pages 13-26.
Crossref
Crossref
Yong Feng & Juan Feng. (2022) Construction of early dyslipidemia index model for nasopharyngeal carcinoma based on laboratory information management system. Construction of early dyslipidemia index model for nasopharyngeal carcinoma based on laboratory information management system.
Lifeng Xiao, Wenyi Kang, Jiayu Liao & Yuru Li. (2022) Efficacy and tolerability of immunotherapy in advanced nasopharyngeal carcinoma with or without chemotherapy: a meta-analysis. Brazilian Journal of Otorhinolaryngology 88, pages S70-S81.
Crossref
Crossref
Zahra Shokati Eshkiki, Shahram Agah, Seidamir Pasha Tabaeian, Meghdad Sedaghat, Fatemeh Dana, Atefeh Talebi & Abolfazl Akbari. (2022) Neoantigens and their clinical applications in human gastrointestinal cancers. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Zijian Liu, Jinlan He & Xiaolin Hu. (2022) Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma. Frontiers in Genetics 13.
Crossref
Crossref
Liu Yang, Guohong Liu, Yirong Li & Yunbao Pan. (2022) The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. Genes & Diseases 9:5, pages 1208-1219.
Crossref
Crossref
Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J. Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon Luah, Chwee Ming Lim, Nivashini Kaliaperumal, Veonice B. Au, Najwa Binte Said Nasir Talib, Reina Sng, John E. Connolly, Boon Cher Goh & Herbert Schwarz. (2021) Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit. Cancer Immunology, Immunotherapy 71:6, pages 1531-1543.
Crossref
Crossref
Jiangying Xuan, Yingxia Liu, Xiaoping Zeng & Hongmei Wang. (2022) Sequence Requirements for miR-424-5p Regulating and Function in Cancers. International Journal of Molecular Sciences 23:7, pages 4037.
Crossref
Crossref
Changyu Zhu, Xiaolei Jiang, Hua Xiao & Jianmei Guan. (2022) Tumor-derived extracellular vesicles inhibit HGF/c-Met and EGF/EGFR pathways to accelerate the radiosensitivity of nasopharyngeal carcinoma cells via microRNA-142-5p delivery. Cell Death Discovery 8:1.
Crossref
Crossref
Zijian Liu, Jinlan He, Jiaqi Han, Jiangping Yang, Wenjun Liao & Nianyong Chen. (2022) m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma. Frontiers in Immunology 12.
Crossref
Crossref
Jian-Ying Xu, Xiao-Li Wei, Yi-Qin Wang & Feng-Hua Wang. (2022) Current status and advances of immunotherapy in nasopharyngeal carcinoma. Therapeutic Advances in Medical Oncology 14, pages 175883592210962.
Crossref
Crossref
Lawrence S. Young, Christopher W. Dawson, Ciaran B. J. Woodman, Charles S. Rabkin & Kwok Wai Lo. 2020. Viral Infections of Humans. Viral Infections of Humans
1
40
.
Qinmin Liu, Lijuan Liu, Chunwei Mo, Xiao Zhou, Dongming Chen, Yu He, Hailu He, Wei Kang, Yongfeng Zhao & Guanqiao Jin. (2021) Polyethylene glycol-coated ultrasmall superparamagnetic iron oxide nanoparticles-coupled sialyl Lewis X nanotheranostic platform for nasopharyngeal carcinoma imaging and photothermal therapy. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Yu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, Xiao-Min Li, Jun-Yan Li, Ya-Qin Wang, Cheng Xu, Ying-Qin Li, Qing-Mei He, Xiao-Jing Yang, Yuan Lei, Jia-Yi Shen, Ling-Long Tang, Lei Chen, Guan-Qun Zhou, Wen-Fei Li, Xiao-Jing Du, Rui Guo, Xu Liu, Yuan Zhang, Jing Zeng, Jing-Ping Yun, Ying Sun, Na Liu & Jun Ma. (2021) Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Molecular Cancer 20:1.
Crossref
Crossref
Qian‐Ying Zhu, Ge‐Xin Zhao, Yan Li, Girish Talakatta, Hai‐Qiang Mai, Quynh‐Thu Le, Lawrence S. Young & Mu‐Sheng Zeng. (2021) Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm 2:2, pages 175-206.
Crossref
Crossref
Luo Huang, Xin Zhang, Yu Bai, Kevin L.M. Chua, Yue Xie, Xiaolei Shu, Bin Long, Chunbo Fan, Darren W.T. Lim, Sze Huey Tan, Joseph T.S. Wee, Ying Wang, Yongzhong Wu & Melvin L.K. Chua. (2021) Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study. Oral Oncology 115, pages 105222.
Crossref
Crossref
Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, Qi Li, Nong Xu, Xi-Chun Hu, Wangjun Liao, Yi Jiang, Xiao-Yan Lin, Qing-yuan Zhang, Xiang-Lin Yuan, Hai-Xin Huang, Ye Chen, Guang-Hai Dai, Jian-Hua Shi, Lin Shen, Shu-Jun Yang, Yong-Qian Shu, Yun-Peng Liu, Weifeng Wang, Hai Wu, Hui Feng, Sheng Yao & Rui-Hua Xu. (2021) Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02). Journal of Clinical Oncology 39:7, pages 704-712.
Crossref
Crossref
Richard Hopkins, Wenwei Xiang, Damien Marlier, Veonice Bijin Au, Qianting Ching, Lynn Xue Wu, Rujun Guan, Bernett Lee, Whay-Kuang Chia, Who-Whong Wang, Joseph Wee, Joanna Ng, Rachael Cheong, Shuting Han, Axel Chu, Chit Lai Chee, Timothy Shuen, Michael Podinger, Alexander Lezhava, Han Chong Toh & John E. Connolly. (2021) Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma. Molecular Therapy 29:2, pages 734-743.
Crossref
Crossref
Ya Cao, Longlong Xie, Feng Shi, Min Tang, Yueshuo Li, Jianmin Hu, Lin Zhao, Luqing Zhao, Xinfang Yu, Xiangjian Luo, Weihua Liao & Ann M. Bode. (2021) Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Birhanu Aberha Berele, Yuxiang Cai & Guifang Yang. (2021) Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis. Technology in Cancer Research & Treatment 20, pages 153303382110342.
Crossref
Crossref
Yuhua Feng, Na Zhang, Sisi Wang, Wen Zou, Yan He, Jin-an Ma, Ping Liu, Xianling Liu, Chunhong Hu & Tao Hou. (2020) Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study. Frontiers in Oncology 10.
Crossref
Crossref
Shanshan Lu, Zhengzheng Yu, Zhiqiang Xiao & Yiya Zhang. (2020) Gene Signatures and Prognostic Values of m6A Genes in Nasopharyngeal Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Liam Masterson, James Howard, Jazmina Gonzalez‐Cruz, Christopher Jackson, Catherine Barnett, Lewis Overton, Howard Liu, Rahul Ladwa, Fiona Simpson, Margie McGrath, Ben Wallwork, Terry Jones, Christian Ottensmeier, Melvin L.K. Chua, Chris Perry, Rajiv Khanna, Benedict Panizza, Sandro Porceddu & Matt Lechner. (2020) Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?. International Journal of Cancer 146:8, pages 2305-2314.
Crossref
Crossref